Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 453972, 10 pages
http://dx.doi.org/10.1155/2014/453972
Review Article

Anticancer Activities of Citrus Peel Polymethoxyflavones Related to Angiogenesis and Others

1Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China
2Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
3Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization, Huanggang Normal University, Huanggang, Hubei 438000, China
4Department of Food Science, Rutgers University, New Brunswick, NJ 08901-8502, USA
5Department of Hematology and Translation Medicine Centre, Hebei Union University Affiliated Hospital, Tangshan, Hebei 063000, China

Received 5 July 2014; Accepted 28 July 2014; Published 28 August 2014

Academic Editor: Zongjin Li

Copyright © 2014 Liwen Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Danihelová and E. Šturdík, “Flavonoid natural sources and their importance in the human diet,” Potravinarstvo, vol. 5, no. 4, pp. 12–24, 2011. View at Google Scholar
  2. K. C. Ock, J. C. Sang, and W. O. Song, “Estimated dietary flavonoid intake and major food sources of U.S. adults,” Journal of Nutrition, vol. 137, no. 5, pp. 1244–1252, 2007. View at Google Scholar · View at Scopus
  3. S. Li, H. Wang, L. Guo, H. Zhao, and C.-T. Ho, “Chemistry and bioactivity of nobiletin and its metabolites,” Journal of Functional Foods, vol. 6, pp. 2–10, 2014. View at Google Scholar
  4. J. M. Assini, E. E. Mulvihill, B. G. Sutherland et al., “Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr/mice,” Journal of Lipid Research, vol. 54, no. 3, pp. 711–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. F. Romagnolo and O. I. Selmin, “Flavonoids and cancer prevention: a review of the evidence,” Journal of Nutrition in Gerontology and Geriatrics, vol. 31, no. 3, pp. 206–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Park and J. M. Pezzuto, “Flavonoids in cancer prevention,” Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 8, pp. 836–851, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. E. Mulvihill and M. W. Huff, “Citrus flavonoids and the prevention of atherosclerosis,” Cardiovascular & Hematological Disorders-Drug Targets, vol. 12, no. 2, pp. 84–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Meiyanto and A. Hermawan, “Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 2, pp. 427–436, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. O. I. Aruoma, B. Landes, D. Ramful-Baboolall et al., “Functional benefits of citrus fruits in the management of diabetes,” Preventive Medicine, vol. 54, pp. S12–S16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hwang, P. Shih, and G. Yen, “Neuroprotective effects of citrus flavonoids,” Journal of Agricultural and Food Chemistry, vol. 60, no. 4, pp. 877–885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Andrews, “Dietary flavonoids for the prevention of colorectal cancer,” Clinical Journal of Oncology Nursing, vol. 17, no. 6, pp. 671–672, 2013. View at Google Scholar
  12. C. La Vecchia, A. Decarli, M. Serafini et al., “Dietary total antioxidant capacity and colorectal cancer: a large case-control study in Italy,” International Journal of Cancer, vol. 133, no. 6, pp. 1447–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Gao, A. Cassidy, M. A. Schwarzschild, E. B. Rimm, and A. Ascherio, “Habitual intake of dietary flavonoids and risk of Parkinson disease,” Neurology, vol. 78, no. 15, pp. 1138–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Song and J. M. Bae, “Citrus fruit intake and breast cancer risk: a quantitative systematic review,” Journal of Breast Cancer, vol. 16, no. 1, pp. 72–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cassidy, E. B. Rimm, É. J. O'Reilly et al., “Dietary flavonoids and risk of stroke in women,” Stroke, vol. 43, no. 4, pp. 946–951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sultana, H. M. Asif, H. M. Nazar, N. Akhtar, J. U. Rehman, and R. U. Rehman, “Medicinal plants combating against cancer—a green anticancer approach,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4385–4394, 2014. View at Google Scholar
  18. X. Grana and E. P. Reddy, “Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs),” Oncogene, vol. 11, no. 2, pp. 211–219, 1995. View at Google Scholar · View at Scopus
  19. K. Vermeulen, D. R. van Bockstaele, and Z. N. Berneman, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer,” Cell Proliferation, vol. 36, no. 3, pp. 131–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. K. I. Park, H. S. Park, A. Nagappan et al., “Induction of the cell cycle arrest and apoptosis by flavonoids isolated from Korean Citrus aurantium L. in non-small-cell lung cancer cells,” Food Chemistry, vol. 135, no. 4, pp. 2728–2735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. J. Choi, “Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21,” Nutrition and Cancer, vol. 59, no. 1, pp. 115–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Alshatwi, E. Ramesh, V. S. Periasamy, and P. Subash-Babu, “The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways,” Fundamental and Clinical Pharmacology, vol. 27, no. 6, pp. 581–592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Arul and P. Subramanian, “Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells,” Pathology and Oncology Research, vol. 19, no. 4, pp. 763–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. Morley, P. J. Ferguson, and J. Koropatnick, “Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells,” Cancer Letters, vol. 251, no. 1, pp. 168–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Charoensinphon, P. Qiu, P. Dong et al., “5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis,” Molecular Nutrition & Food Research, vol. 57, no. 12, pp. 2103–2111, 2013. View at Publisher · View at Google Scholar
  26. P. Qiu, H. Guan, P. Dong et al., “The p53-, Bax- and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones,” Molecular Nutrition and Food Research, vol. 55, no. 4, pp. 613–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Li, B. Yang, J. Huang et al., “Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway,” Toxicology Letters, vol. 220, no. 3, pp. 219–228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Han, W. S. Lee, J. N. Lu et al., “Citrus aurantium L. exhibits apoptotic effects on U937 human leukemia cells partly through inhibition of Akt,” International Journal of Oncology, vol. 40, no. 6, pp. 2090–2096, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Ghorbani, M. Nazari, M. Jeddi-Tehrani, and H. Zand, “The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism,” European Journal of Nutrition, vol. 51, no. 1, pp. 39–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Wesołowska, J. Wiśniewski, K. Środa-Pomianek et al., “Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants,” Journal of Natural Products, vol. 75, no. 11, pp. 1896–1902, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Gosslau, K. Y. Chen, C.-T. Ho, and S. Li, “Anti-inflammatory effects of characterized orange peel extracts enriched with bioactive polymethoxyflavones,” Food Science and Human Wellness, vol. 3, no. 1, pp. 26–35, 2014. View at Google Scholar
  32. I. N. Sergeev, C. T. Ho, S. Li, J. Colby, and S. Dushenkov, “Apoptosis-inducing activity of hydroxylated polymethoxyf lavones and polymethoxyflavones from orange peel in human breast cancer cells,” Molecular Nutrition and Food Research, vol. 51, no. 12, pp. 1478–1484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. S. Lai, S. Li, C. B. Liu et al., “Effective suppression of azoxymethane-induced aberrant crypt foci formation in mice with citrus peel flavonoids,” Molecular Nutrition and Food Research, vol. 57, no. 3, pp. 551–555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Li, Y. C. Lin, C. T. Ho et al., “Formulated extract from multiple citrus peels impairs dendritic cell functions and attenuates allergic contact hypersensitivity,” International Immunopharmacology, vol. 20, no. 1, pp. 12–23, 2014. View at Google Scholar
  35. N. Nalini, S. Aranganathan, and J. Kabalimurthy, “Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis,” Toxicology Mechanisms and Methods, vol. 22, no. 5, pp. 397–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Ye, F. L. Chan, S. Chen, and L. K. Leung, “The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice,” Journal of Nutritional Biochemistry, vol. 23, no. 10, pp. 1230–1237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Candé, N. Vahsen, C. Garrido, and G. Kroemer, “Apoptosis-inducing factor (AIF): caspase-independent after all,” Cell Death and Differentiation, vol. 11, no. 6, pp. 591–595, 2004. View at Google Scholar · View at Scopus
  38. C. Lu, F. Zhu, Y. Cho et al., “Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3,” Molecular Cell, vol. 23, no. 1, pp. 121–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Wang, Y. Duan, D. Zhi et al., “Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4′-tetramethylnortangeretin on MCF-7 breast cancer cells,” Cell Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  40. C. Fimognari, M. Nüsse, M. Lenzi, D. Sciuscio, G. Cantelli-Forti, and P. Hrelia, “Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 601, no. 1-2, pp. 92–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Bast, H. Kaiserová, G. J. den Hartog, G. R. Haenen, and W. J. F. van der Vijgh, “Protectors against doxorubicin-induced cardiotoxicity: flavonoids,” Cell Biology and Toxicology, vol. 23, no. 1, pp. 39–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Hermawan, “Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells,” Indonesian Journal of Pharmacy, vol. 21, no. 1, pp. 8–16, 2010. View at Google Scholar
  43. A. Ahmadi, S. J. Hosseinimehr, F. Naghshvar, E. Hajir, and M. Ghahremani, “Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells,” Archives of Pharmacal Research, vol. 31, no. 6, pp. 794–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. E. Talmadge and I. J. Fidler, “AACR centennial series: the biology of cancer metastasis: historical perspective,” Cancer Research, vol. 70, no. 14, pp. 5649–5669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Lee, D. Kim, W. Kim, and S. Moon, “Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-α-induced vascular smooth muscle cells,” Molecular Nutrition and Food Research, vol. 53, no. 12, pp. 1582–1591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. E. A. Goncharova, A. J. Ammit, C. Irani et al., “PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 283, no. 2, pp. L354–L363, 2002. View at Google Scholar · View at Scopus
  47. J. Seo, H. S. Lee, S. Ryoo, J. H. Seo, B. Min, and J. H. Lee, “Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation,” European Journal of Pharmacology, vol. 673, no. 1–3, pp. 56–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Chen, Y. Ding, W. Tao, W. Zhang, T. Liang, and C. Liu, “Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1,” Food and Chemical Toxicology, vol. 50, no. 9, pp. 3025–3031, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Lai, S. Li, Y. Miyauchi, M. Suzawa, C. Ho, and M. Pan, “Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors,” Food and Function, vol. 4, no. 6, pp. 944–949, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. N. M. Pandya, N. S. Dhalla, and D. D. Santani, “Angiogenesis—a new target for future therapy,” Vascular Pharmacology, vol. 44, no. 5, pp. 265–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. T. A. Bhat and R. P. Singh, “Tumor angiogenesis: a potential target in cancer chemoprevention,” Food and Chemical Toxicology, vol. 46, no. 4, pp. 1334–1345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Kunimasa, M. Ikekita, M. Sato et al., “Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo,” Cancer Science, vol. 101, no. 11, pp. 2462–2469, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. I. K. Lam, D. Alex, Y. H. Wang et al., “In vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: identifying sinensetin as a novel antiangiogenesis agent,” Molecular Nutrition and Food Research, vol. 56, no. 6, pp. 945–956, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. K. H. Lam, D. Alex, I. K. Lam, S. K. W. Tsui, Z. F. Yang, and S. M. Y. Lee, “Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model,” Journal of Cellular Biochemistry, vol. 112, no. 11, pp. 3313–3321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Lakshmi and S. Subramanian, “Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats,” Biochimie, vol. 99, pp. 96–109, 2014. View at Google Scholar
  57. S. A. B. E. van Acker, M. J. de Groot, D. D. van Berg et al., “A quantum chemical explanation of the antioxidant activity of flavonoids,” Chemical Research in Toxicology, vol. 9, no. 8, pp. 1305–1312, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, “Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships,” Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572–584, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Mishra, K. I. Priyadarsini, M. S. Kumar, M. K. Unnikrishnan, and H. Mohan, “Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol,” Bioorganic and Medicinal Chemistry, vol. 11, no. 13, pp. 2677–2685, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Amić and B. Lučić, “Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids,” Bioorganic and Medicinal Chemistry, vol. 18, no. 1, pp. 28–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Zheng, M. Song, P. Dong et al., “Identification of novel bioactive metabolites of 5-demethylnobiletin in mice,” Molecular Nutrition & Food Research, vol. 57, no. 11, pp. 1999–2007, 2013. View at Google Scholar
  62. S. Li, M.-H. Pan, C.-Y. Lo et al., “Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones,” Journal of Functional Foods, vol. 1, no. 1, pp. 2–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Dong, P. Qiu, Y. Zhu et al., “Simultaneous determination of four 5-hydroxy polymethoxyflavones by reversed-phase high performance liquid chromatography with electrochemical detection,” Journal of Chromatography A, vol. 1217, no. 5, pp. 642–647, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Li, Z. Wang, S. Sang, M. T. Huang, and C. T. Ho, “Identification of nobiletin metabolites in mouse urine,” Molecular Nutrition and Food Research, vol. 50, no. 3, pp. 291–299, 2006. View at Publisher · View at Google Scholar · View at Scopus